Liver-Specific Particulate Contrast Agents: An Overview

  • K. Ivancev
  • A. Lunderquist
Conference paper
Part of the Frontiers in European Radiology book series (FER, volume 9)

Abstract

Treatment of hepatic metastases, predominantely from colorectal carcinoma, is a major problem in Europe and the USA. Each year 140 000 new cases present in the USA (Sugarbaker 1990). Approximately 7000 of these patients require hepatic resection, the only treatment currently providing 25%-50% long-term survival (Sugarbaker 1990; Sugarbaker and Kemeny 1989). Surgical removal with similar favorable results of hepatic metastases from endocrine tumors as well as from renal cell carcinomas, adrenal carcinomas, leiomyosarcomas, melanomas, and pancreatic carcinomas in selected patients has also been reported (Sugarbaker and Kemeny 1989). In addition, hepatocellular carcinoma (HCC), the most common primary liver carcinoma is the leading cause of cancer mortality in Southeast Asia and sub-Saharan Africa, with an extensive number of people affected (Schonland et al. 1985). Similar to hepatic resections for metastases, resection of small (< 5 cm) HCC, when feasible with regard to cirrhosis, has also prolonged the survival of these patients (Ohnishi et al. 1987).

Keywords

Toxicity Ferrite Lipase Magnetite Thrombocytopenia 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Altura BM, Gebrewold A (1985) Chemical blockade of the reticuloendothelial system results in arteriolar spasm. Possible role of endothelial cells. Microcirc Endothelium Lymphatics 2: 151–159.PubMedGoogle Scholar
  2. Beckerman F, Popkin C (1938) Kontrastdarstellung der Leber und Milz im Roentgenbild mit Jodsolen. Fortschr Rontgenstr 58: 519–535Google Scholar
  3. Belin RP, Bivins BA, Jona JZ, Young VL (1976) Fat overload with a 10% soybean oil emulsion. Arch Surg 111: 1391–1393PubMedCrossRefGoogle Scholar
  4. Bennett WF, Bova JG (1990) Review of hepatic imaging and a problem-oriented approach to liver masses. Hepatology 12: 761–775PubMedCrossRefGoogle Scholar
  5. Berger SM (1956) Angiopac, ethyl de-iodostearate as a hepatosplenographic agent. Preliminary report. AJ 76: 39–46Google Scholar
  6. Bernheim HA (1985) Temperature regulation and fever. In: Reichard SM, Filkins JP (eds) The reticuloendothelial system. A comprehensive treatise, vol 7B. Plenum, New York, pp 339–353Google Scholar
  7. Bruneton JN, Falewee MN, Francois E et al. (1989) Liver, spleen and vessels. Preliminary clinical results of CT with perfluorooctylbromide. Radiology 170: 179–183PubMedGoogle Scholar
  8. Cheng KT, Seltzer SE (1987) Liposome-encapsulated contrast agents in diagnostic imaging. In: Parvez Z, Moncada R, Sovak M (eds) Contrast media. Biologic effects and clinical application, vol III. CRC Press, Boca Raton, pp 73–87Google Scholar
  9. Cohen Z, Seltzer SE, Davis MA, Hanson RN (1981) Iodinated starch particles. New contrast material for computed tomography of the liver. J Comput Assist Tomogr 5: 843–846PubMedCrossRefGoogle Scholar
  10. Counsell RE, Weichert JP (1990) Targeting strategies for organ imaging agents. Course no 122, presented at the 76th scientific assembly and annual meeting Radiological Society of North America, Nov 1990Google Scholar
  11. De Toit DF, Villet WT, Heydenrych J (1978) Fat-emulsion deposition in mononuclear phagocytic system. Lancet 10: 898CrossRefGoogle Scholar
  12. Di Luzio NR, Blickens DA (1966) Influence of intravenously administered lipids on reticuloendothelial function. J Reticuloendothel Soc 3: 250–270PubMedGoogle Scholar
  13. Discher HW (1977) Improvement in radiographic contrast media through the development of colloidal or particulate media. An analysis. J Theor Biol 67: 653–670CrossRefGoogle Scholar
  14. Erkelens DW, Brunzell JD, Bierman EL (1979) Availability of apolipoprotein CII in relation to the maximal removal capacity for an infused triglyceride emulsion in man. Metabolism 28: 495PubMedCrossRefGoogle Scholar
  15. Fahlvik AK, Holtz E, Klaveness J (1990) Superparamagnetic starch microspheres: a reticuloendothelial MRI contrast agent. In: Ferrucci JT, Stark DD (eds) Liver imaging. Current trends and new techniques. Andover Medical Publishers, Reading, pp 425–429Google Scholar
  16. Ferrucci JT (1990a) Liver tumor imaging: issues for the 1990s. In: Ferrucci JT, Stark DD (eds) Liver imaging. Current trends and new techniques. Andover Medical Publishers, Reading, pp 1–18Google Scholar
  17. Ferrucci JT (1990b) Ferrite particles: rationale and clinical results (Midfield). In: Ferrucci JT, Stark DD (eds) Liver imaging. Current trends and new techniques. Andover Medical Publishers, Reading, pp 403–414Google Scholar
  18. Forbes GB (1978) Splenic lipidosis after administration of intravenous fat emulsions. J Clin Pathol 31:765–771PubMedCrossRefGoogle Scholar
  19. Forgac M (1988) Receptor-mediated endocytosis. In: Arias IM, Jakoby WB, Popper H, Schachter D, Shafritz DA The liver: biology and pathobiology, 2nd edn. Raven, New York, pp 207–225Google Scholar
  20. Freud U, Krausz Y, Levij IS, Eliakim M (1975) Iatrogenic lipidosis following prolonged intravenous hyperalimentation. Am J Clin Nutr 28: 1156–1160Google Scholar
  21. Gjoen T, Holtz E, Stande P, Klaveness J, Leander P, Berg A (1990) Particulate biodegradable contrast medium for CT of the liver. In: Ferrucci JT, Stark DD (eds) Liver imaging. Current trends and new techniques, vol XV. Andover Medical publishers, Reading, pp 394–402Google Scholar
  22. Glazer GM, Longino MA, Schwendner SW, Counsell RE, Weichert JP (1983) Lipid soluble contrast agents for computed tomography of the liver. Results with cholesterol iopanoate. J Comput Assist Tomogr 7: 775–779PubMedCrossRefGoogle Scholar
  23. Grossman ME, Cooray CH (1949) An experimental study of an iodine emulsion for hepato-lienography. J Fac Radiol 1: 112–120CrossRefGoogle Scholar
  24. Hallberg D (1965) Elimination of exogenous lipids from the blood stream. An experimental, methodological and clinical study. Thesis, University of StockholmGoogle Scholar
  25. Hartmut J, Smith CW, Farhood A (1990) The pathophysiological role of kupffer cells and neutrophils in hepatic ischemia/reperfusion injury in vivo. 5th international symposium on cells of the hepatic sinusoid. Tucson, AzGoogle Scholar
  26. Heiken Jp, Weyman PJ, Lee JKT, Balfe DM, Picus D, Brunt EM, Flye MW (1989) Detection of focal hepatic masses: prospective evaluation with CT, delayed CT, CT during arterial portography, and MR imaging. Radiology 171: 47–51PubMedGoogle Scholar
  27. Ivancev K, Lunderquist A, McCuskey R, McCuskey P, Wretlind A (1989a) Effect of intravenously injected iodinated lipid emulsions on the liver. Acta Radiol 30: 291–298PubMedCrossRefGoogle Scholar
  28. Ivancev K, Lunderquist A, McCuskey R, McCuskey P, Wretlind A (1989b) Experimental investigation of a new iodinated lipid emulsion for computed tomography of the liver. Acta Radiol 30: 407PubMedCrossRefGoogle Scholar
  29. Ivancev K, Lunderquist A, Isaksson A, Hochbergs P, Wretlind A (1989c) Clinical trials with a new iodinated lipid emulsion for computed tomography of the liver. Acta Radiol 30: 449–457PubMedCrossRefGoogle Scholar
  30. Johansson S, Sternby NH, Theander G, Wehlin L (1966) Iodinated oil emulsion for lymphography. Acta Radiol Diagn 4: 690–704Google Scholar
  31. Jones EA, Summerfield JA (1988) Kupffer cells. In: Arias IM, Jakoby WB, Popper H, Schachter D, Schafritz DA (eds). The liver. Biology and pathobiology, 2nd edn. Raven, New York, pp 683–704Google Scholar
  32. Kaplan JE, Moon DG (1984) Platelets. In: Reichard SM, Filkins JP (eds) The reticuloendothelial system. A comprehensive treatise, vol. 7A. Plenum, New York, pp 237–266Google Scholar
  33. Keith WS, Briggs DK (1930) Roentgen ray visualization of the spleen following injection of emulsions of halogenated oils. Proc Soc Exp Biol 27: 538–540Google Scholar
  34. Koudstaal J, Dijkhuis FWJ, Hardonk MJ (1990) Selective depletion of Kupffer cells in rats by gadolinium chloride. 5th international symposium on cells of the hepatic sinusoid, Tucson, Arizona,Google Scholar
  35. Lamarque JL, Bruel JM, Dondelinger R et al. (1979) The use of iodolipids in hepatosplenic computed tomography. J Comput Assist Tomogr 3: 21–24PubMedCrossRefGoogle Scholar
  36. Laval-Jeantet M, Lamarque JL, Dreux P, Laval-Jeantet AM, Launay J (1976) Hepatosplenography by intravenous injection of a new iodized oily emulsion. Acta Radiol Diagn 17: 49–60Google Scholar
  37. Ledoux-Lebard GM (1939) L’hepatosplenographie. Etude experimentale et clinique. Essai d’une nouvelle methode. Thesis ParisGoogle Scholar
  38. Lewis E, Aufderheide JF, Bernardino ME, Barnes PA, Thomas JL (1982) CT detection of hepatic metastases with ethiodized oil emulsion 13. J Comput Assist Tomogr 6: 1108–1114PubMedCrossRefGoogle Scholar
  39. Mattrey RF, Shelton RE (1987) Prefluorocarbon emulsions in diagnostic imaging. An overview and some experimental considerations. In: Parvez Z, Moncada R, Sovak M (eds) Contrast media. Biologic effects and clinical application, vol III. CRC Press, Boca Raton, pp 105–131Google Scholar
  40. Marchai G, van Hecke P, Demaerel P, Decrop E, Baert AL (1990) Iron oxide: high-field MRI clinical results. In: Ferrucci JT, Stark DD (eds) Liver imaging. Current trends and new techniques. Andover Medical Publishers, Reading, pp 415–424Google Scholar
  41. Merine D, Takayasu K, Wakao F (1990) Detection of hepatocellular carcinoma: comparison of CT during arterial, portography with CT after intraarterial injection of iodized oil. Radiology 175: 707–710PubMedGoogle Scholar
  42. Miller DL, O’Leary T, Vucich JJ, Girton M, Vermess M, Doppman JL (1983) Experimental evaluation of five liver-spleen specific CT contrast agents. J Comput Assist Tomogr 7: 1022–1028PubMedCrossRefGoogle Scholar
  43. Miller DL, Vermess M, Doppman JL et al. (1984) CT of the liver and spleen with EOE-13. Review of 225 examinations. AJR 143: 235–243PubMedGoogle Scholar
  44. Montazel JL, Mathieu D, Derhy S, Arthaud A, Rahmouni A, Roche A (1990) Superparamagnetic iron oxide: detection of liver tumors at different concentrations—Results of MR imaging at 1.5 T. Presented at the 76th scientific assembly and annual meeting of the Radiological Society of North America, Nov 1990Google Scholar
  45. Nordenstrom J (1982) Utilization of exogenous and endogenous lipids for energy production during parenteral nutrition. Thesis, University of StockholmGoogle Scholar
  46. Ohnishi K, Tanabe Y, Ryu M et al. (1987) Prognosis of hepatocellular carcinoma smaller than 5 cm in relation to treatment. Study of 100 patients. Hepatology 7: 1285–1290PubMedCrossRefGoogle Scholar
  47. Olsson O (1942) On hepatosplenography with “Jodsol. Acta Radiol Diagn 22: 749–761CrossRefGoogle Scholar
  48. Pacciucci PA, Mandeli J, Oleksowicz L, Ameglio F, Holland JF (1990) Thrombocytopenia during immunotherapy with interleukin-2 by constant infusion. Am J Med 89: 308–312CrossRefGoogle Scholar
  49. Platanias LC, Vogelzang NJ (1990) Interleukin-1: biology, pathophysiology and clinical prospects. Am J Med 89: 621–629PubMedCrossRefGoogle Scholar
  50. Radt P (1929) Eine methode zur rontgenologischen kontrastdarstellung von Milz und Leber. Klin Wochenschr 8: 2128–2129CrossRefGoogle Scholar
  51. Reeves DL, Stuck RM (1938) Clinical and experimental results with Thorotrast. Medicine 17: 37–73Google Scholar
  52. Reichard SM, Filkins JP (eds) (1985) The reticuloendothelial system. A comprehensive treatise, vol, 7B. Plenum, New YorkGoogle Scholar
  53. Reimer P, Weissleder R, Lee AS, Wittenberg J, Brady TJ (1990) Receptor imaging: application to MR imaging of liver cancer. Radiology 177: 729–734PubMedGoogle Scholar
  54. Rossner S (1974) Studies on an intravenous fat tolerance test. Methodological, experimental and clinical experiences with Intralipid. Thesis, University of StockholmGoogle Scholar
  55. Saba TM (1970) Physiology and physiopathology of the reticuloendothelial system. Arch Intern Med 126; 1031–1051PubMedCrossRefGoogle Scholar
  56. Schlayer HJ, Karck U, Ganter U, Hermann R, Decker K (1987) Enhancement of neutrophil adherence to isolated rat liver sinusoidal endothelial cells by supernatants of lipopolysaccharide-activated monocytes. Role of tumor necrosis factor. J Hepatol 5: 311–321PubMedCrossRefGoogle Scholar
  57. Schoefl GI (1968) The ultrastructure of chylomicra and of the particles in an artificial fat emulsion. Proc R Soc [Biol] 169: 147–152CrossRefGoogle Scholar
  58. Scholler KL (1973) Zur Speicherung verschiedener Fettemulsionen in den Retikuloendothelzellen der Leber. Med Welt 24: 1179–1181PubMedGoogle Scholar
  59. Schonland MM, Millward-Sadler GH, Wright DH, Wright R: Hepatic tumours. In: Wright R, Millward-Sadler GH, Alberti KGMM, Karran S (eds) Liver and biliary disease. Pathophysiology, diagnosis, management, 2nd edn. Bailliere Tindall Saunders, London, pp 1137–1184Google Scholar
  60. Schuberth O, Wretlind A (1961) Intravenous infusion of fat emulsions, phosphatides and emulsifying agents. Clinical and experimental studies. Acta Chir Scand [Suppl] 278:Google Scholar
  61. Schwendener RA, Wuthrich R, Duewell S, Wehrli E, von Schulthess GK (1990) A pharmacokinetic and MRI study of unilamellar gadolinium-, manganese-, and iron-DTPA-stearate liposomes as organ-specific contrast agents. Invest Radiol 25: 922–932PubMedCrossRefGoogle Scholar
  62. Seltzer SE (1989) The role of liposomes in diagnostic imaging. Radiology 171: 19–21PubMedGoogle Scholar
  63. Shenkin A, Wretlind A (1978) Parenteral nutrition. World Rev Nutr Diet 28: 1–111PubMedGoogle Scholar
  64. Shepherd J, Packard CJ (1989) Lipoprotein metabolism. In: Fruchart JC, Shepherd J (eds) Human plasma lipoproteins. De Gruyter, Berlin, pp 55–78Google Scholar
  65. Stark DD (1990) Principles for design of liver contrast agents. In: Ferrucci JT, Stark DD (eds) Liver imaging. Current trends and new techniques. Andover Medical Publishers, Reading, p 326.Google Scholar
  66. Sugarbaker PH (1990) Surgical decision making for large bowel cancer metastatic to the liver. Radiology 174: 621–626PubMedGoogle Scholar
  67. Sugarbaker PH, Kemeny N (1989) Management of metastatic cancer to the liver. Adv Surg 22: 1–56PubMedGoogle Scholar
  68. Swarm RL (1971) Colloidal thorium dioxide. In: Knoefel PK (ed) International encyclopedia of pharmacology and therapeutics. Radioactive agents, sect 76, vol II. Pergamon, Oxford pp 431–441Google Scholar
  69. Teplick JG, Haskin ME, Skelley J, Wohl GT, Sanen F (1964) Experimental studies with a new radiopaque emulsion. AJR 82: 478–485Google Scholar
  70. Thomas SF, Henry GW, Kaplan HS (1957) Hepatolienography. Past, present, and future. Radiology 57: 669–684Google Scholar
  71. Thompson SW (1974a) Clinical experience with the intravenous infusion of lipid emulsions. In: Thompson SW (ed) The pathology of parenteral nutrition with lipids. Thomas, Springfield, p 111Google Scholar
  72. Thompson SW (1974b) Microscopic and ultrastructural pathology. In: Thompson SW (ed) The pathology of parenteral nutrition with lipids. Thomas, Springfield, p 661Google Scholar
  73. Thompson SW (1974c) Histochemical profile, etiology and significance of intravenous fat pigment. In: Thompson SW (ed) The pathology of parenteral nutrition with lipids. Thomas, Springfield, p 801Google Scholar
  74. Thompson SW, Jones LD, Ferrel JF et al. (1965) Testing of fat emulsions for toxicity. III. Toxicity studies with new fat emulsions and emulsion components. Am J Clin Nutr 16: 43–61PubMedGoogle Scholar
  75. Thurman RG, Lindert KA, Cowper KB, te Koppele JM, Dawson TL, Currin RT, Takei Y, Marzi I, Lemasters JJ (1990) Continuous monitoring of Kupffer cell phagocytosis in the isolated, perfused rat liver and its application to liver transplantation. 5th international symposium on cells of the hepatic sinusoid. Tucson, ArizonaGoogle Scholar
  76. Tilcock C, Unger E, Cullis P, MacDougall P (1989) Liposomal Gd-DTPA: preparation and characterization of relaxivity. Radiology 171: 77–80PubMedGoogle Scholar
  77. Untracht SH (1982) Intravascular metabolism of an artificial transporter of triacylglycerols. Alterations of serum lipoproteins resulting from total parenteral nutrition with Intralipid. Biochim Biophys Acta 711: 176–192PubMedGoogle Scholar
  78. US pharmacopeia (1985) 21st edition. Ethiodized oil injection, pp 412–413Google Scholar
  79. Van Haelst UJGM, Sengers RCA (1976) Effects of parenteral nutrition with lipids on the human liver. An electron-microscopic study. Virchows Arch [B] 22: 323–332Google Scholar
  80. Vermess M, Chatterji DC, Doppman JL, Grimes G, Adamson PH (1979) Development and experimental evaluation of a contrast medium for computed tomographic examination of the liver and spleen. J Comput Assist Tomogr 3: 25–31PubMedCrossRefGoogle Scholar
  81. Vermess M, Doppman JL, Sugarbaker PH et al. (1980) Clinical trials with a new intravenous liposoluble contrast material for computed tomography of the liver and spleen. Radiology 137: 217–222PubMedGoogle Scholar
  82. Vermess M, Doppman JL, Sugarbaker PH et al. (1982) Computed tomography of the liver and spleen with intravenous lipoid contrast material. Review of 60 examinations. AJR 138: 1061–1071Google Scholar
  83. Vermess M, Chatterji DC, Grimes Jr GJ, Gallelli JF (1983) Ethiodized oil emulsion for intravenous hepatography. United States patent 4,404,182, 13, Sept, 1983Google Scholar
  84. Vilaro S, Llobera M (1988) Uptake and metabolism of Intralipid by rat liver. An electron-microscopic study. J Nutr 118:932–940PubMedGoogle Scholar
  85. Violante MR, Fischer HW (1987) Efficacy and safety of IDE particulate suspensions for liver CT enhancement. In: Parvez Z, Moncada R, Sovak M (eds) Contrast media. Biologic effects and clinical application, vol III. CRC Press, Boca Raton, pp 89–103Google Scholar
  86. Wake K, Kaneda K, Kishiye T, Yamamoto H (1990) Cinematographic observations on sinusoidal microcirculation and NK activity of liver-associated LGLs (pit cells) after administration of BRM (OK-432). 5th international symposium on cells of the hepatic sinusoid. Tucson, Arizona, Aug 1990Google Scholar
  87. Wardle EN (1987) Kupffer cells and their function. Liver 7: 63–75PubMedGoogle Scholar
  88. Weissleder R, Start DD, Engelstad BL, Bacon BR, Compton CC, White DL, Jacobs P, Lewis J (1989) Superparamagnetic iron oxide. Paramacokinetics and toxicity. AJR 152: 167–173PubMedGoogle Scholar
  89. Weissleder R, Reimer P, Lee AS, Wittenberg J, Brady TJ (1990) MR receptor imaging: Ultrasmall iron oxide particles targeted to asialoglycoprotein receptors. RJR 155: 1161–1167Google Scholar
  90. Wiedmeier VT, Johnson SA, Siegesmund KA, Smith JJ (1969) Systemic effects of RES blocking agents in the dog. J Reticuloendothel Soc 6: 202–220PubMedGoogle Scholar
  91. Wiedmeier VT, Stekiel WJ, Smith JJ (1970) The mechanism of colloid shock. J Reticuloendothel Soc 7: 716–730PubMedGoogle Scholar
  92. Wolf GL (1989) Current status of MR imaging contrast agents: special report. Radiology 172: 709–710PubMedGoogle Scholar
  93. Wretlind A (1981) Development of fat emulsions. J Parent Ent Nutr 5: 230–235CrossRefGoogle Scholar
  94. Young SP, Aisen P (1988) The liver and iron. In: Arias IM, Jakoby WB, Popper H, Schachter D, Shafritz DA (eds) The liver: biology and pathobiology, 2nd edn. Raven, New York, p 535Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • K. Ivancev
    • 1
  • A. Lunderquist
    • 1
  1. 1.Department of RadiologyLundSweden

Personalised recommendations